Comments
Loading...
Biote (NASDAQ:BTMD) Stock Quotes, Forecast and News Summary
Biote Stock (NASDAQ: BTMD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biote (BTMD) stock?
You can purchase shares of Biote (NASDAQ:BTMD) through any online brokerage.
Who are Biote (BTMD) competitors?
Other companies in Biote’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Xeris Biopharma Holdings (NASDAQ:XERS), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Telomir Pharmaceuticals (NASDAQ:TELO).
What is the forecast, or price target, for Biote (BTMD) stock?
Biote has a consensus price target of $8.65.
What is the current price for Biote (BTMD)?
The stock price for Biote (NASDAQ: BTMD) is $6.07 last updated November 21, 2024 at 1:04 PM EST.
Does Biote (BTMD) pay a dividend?
There are no upcoming dividends for Biote.
When is Biote (NASDAQ:BTMD) reporting earnings?
Biote’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Biote (BTMD) going to split?
There is no upcoming split for Biote.
What sector and industry does Biote (BTMD) operate in?
Biote is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.